Rejuvenate Bio
Developing novel therapies to reverse aging and extend lifespan.
About
Technology stack
detected 2026-06-14
Squarespace“Rejuvenate Bio lands $4m CIRM grant for gene-therapy research.”
View on Reddit“Interview with Rejuvenate Bio CEO on liver-directed gene therapy program targeting FGF21 in dogs and humans.”
View on Reddit“Rejuvenate Bio first to publish study showing that epigenetic reprogramming extends lifespan in 'normal' mice..”
View on Reddit“Rejuvenate Bio first to publish study showing that epigenetic reprogramming extends lifespan in 'normal' mice.”
View on Reddit“Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan.”
View on Reddit“Rejuvenate Bio raises $10M for gene therapy for aging in dogs and humans, co-founded by Harvard Medical School geneticist George Church.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
What does Rejuvenate Bio do?
Rejuvenate Bio is a biotechnology company focused on developing novel therapies to reverse aging and extend lifespan. The company's approach leverages advancements in genetic engineering and regenerative medicine to target the fundamental mechanisms of aging. Their research aims to create treatments that can restore youthful function to tissues and organs, ultimately leading to healthier and longer lives for both humans and animals.
How much funding has Rejuvenate Bio raised?
Rejuvenate Bio has raised a total of $106M in funding. The most recent round on record is Financing.
Where is Rejuvenate Bio headquartered?
Rejuvenate Bio is headquartered in Cambridge, Massachusetts, USA.
When was Rejuvenate Bio founded?
Rejuvenate Bio was founded in 2018.
What industry does Rejuvenate Bio operate in?
Rejuvenate Bio operates in Biotechnology, Healthcare, Genetics, Longevity, Biotech, HealthTech.
How many employees does Rejuvenate Bio have?
Rejuvenate Bio has approximately 16 people on record.